ÂÜÀòÂÒÂ×

Mr. Ong Chee Tian joined the company as a Quality Manager in 2011 and was assigned to project management a few years later. He was promoted to the position of Deputy Technical Director in 2019 to oversee the technical operations of our group of companies. He also takes an active role in the development of the company’s proprietary Umbilical Cord Lining Stem Cells platform technology into therapeutic applications with a focus on diseases with unmet medical needs. These projects are conducted through collaborations with research institutions in Singapore as well as institutions overseas. One major milestone was the successful development of a US-FDA clinical-grade Cord Lining-Mesenchymal Stem Cell line which is currently used in a clinical trial for chronic diabetic foot ulcers in the US.

Before joining CellResearch, he was a Research Officer screening for mutations in low-risk cancer markers in breast cancer patients who tested negative for BRAC1 in the Breast and Cancer Molecular Biology Research Group, and investigating the role of epithelial-mesenchymal interactions in the pathogenesis of keloid scars in Skin and Stem Cell Research Group at the National University Hospital System (NUHS). Mr. Ong started his career as a Technical Officer in Purification Process Development at A-Biopharma Pte Ltd, a biopharmaceutical contract manufacturer. He was responsible for optimizing the protocol for purifying protein products to achieve the highest recovery yield in the shortest time and at the most economical cost.

Mr. Ong was an architectural student at Singapore Polytechnic before realizing his interest in bio-science. He dropped out of the architecture course and joined the Biotechnology Diploma course and subsequently graduated with a Bachelor of Science from the Curtin University of Technology, Western Australia. He believes that the future of health care lies in the limitless regenerative potentials of Stem Cells.